| Product Name | MF | CAS | Details |
|---|
| Patritumab deruxtecan | 2227102-46-5 | Details |
| Pateamine A | C31H45N3O4S | 139220-18-1 | Details |
| Niravoline | C22H25N3O3 | 130610-93-4 | Details |
| Bulgecin A | C16H29N3O14S2 | 92953-54-3 | Details |
| Ambrein | C30H52O | 473-03-0 | Details |
| M-COPA | C25H34N2O2 | 861718-91-4 | Details |
| Foslevodopa | C9H12NO7P | 97321-87-4 | Details |
| GS-9822 | C36H39ClN4O4S | 2219362-41-9 | Details |
| Naltrindole | C26H26N2O3 | 111555-53-4 | Details |
| Orniplabin | C51 H68 N2 O10 | 733805-92-0 | Details |
| Berubicin HCl | C34H35NO11. HCl | 293736-67-1 | Details |
| 5-Fluoromethylornithine dihydrochloride | C6H14ClFN2O2 | 124796-41-4 | Details |
| Mequitamium | C21H25N2S+ | 101396-46-7 | Details |
| Ras inhibitor 134 | 2648552-54-7 | Details |
| Ainsliadimer A | C30H34O7 | 1039431-94-1 | Details |
| Mal-PEG2-Val-Cit-PABA | C27H38N6O9 | 1662687-83-3 | Details |
| Glycolithocholic acid 3-sulfate | C26H43NO7S | 15324-64-8 | Details |
| Compound STL565749 | C19H17N3O | 879771-67-2 | Details |
| CeMMEC1 HCl | C19H17ClN2O4 | 2095432-53-2 | Details |
| VKGILS-NH2 TFA | C30H55F3N8O9 | 2828432-41-1 | Details |
| URAT1 inhibitor 8 | 1632005-33-4 | Details |
| NLRP3-IN-18 | C19H18ClN3O | 2769040-06-2 | Details |
| AA74-1 | C16H28N4O2 | 1361532-00-4 | Details |
| FEN1-IN-5 | C21H17N3O4S | 824983-93-9 | Details |
| Canlitinib | C33H31F2N3O7 | 2222730-78-9 | Details |
| Bleximenib oxalate | 2866179-95-3 | Details |
| EGGGG-PEG8-amide-bis(deoxyglucitol) | 2842855-38-1 | Details |
| GlcNAcstatin | C20H27N3O4 | 922163-64-2 | Details |
| HDAC-IN-55 | C17H17N3O3 | 1268674-16-3 | Details |
| Bio-AMS | C20H29N9O7S2 | 1393881-52-1 | Details |
| SNIPER(TACC3)-11 | 2906151-68-4 | Details |
| TMV-IN-3 | 2883408-35-1 | Details |
| KRAS inhibitor FB9 | C23H21ClF4N2O5 | 2042365-57-9 | Details |
| PB038 | C98H149FN12O36 | 2851058-71-2 | Details |
| BDM91270 | 2892824-11-0 | Details |
| JAK-IN-25 | C19H17N5O4 | 2127110-22-7 | Details |
| TMV-IN-2 | 2883408-32-8 | Details |
| ELOVL6-IN-3 | C27H24F3N3O3 | 712346-06-0 | Details |
| NSC194598 | C20H19N3O | 5358-76-9 | Details |
| MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-Exatecan | C55H60FN9O13 | 2414393-22-7 | Details |
| ERK1/2 inhibitor 9 | 2169302-75-2 | Details |
| MMV009085 | C22H22N2O6 | 298217-59-1 | Details |
| Metronidazole hydrochloride | C6H9N3O3.ClH | 69198-10-3 | Details |
| Skp2 inhibitor 2 | 2760612-77-7 | Details |
| Tirilazad | C38H52N6O2 | 110101-66-1 | Details |
| 3,7-dimethylocta-2,6-dienyl 5,9,13-trimethyltetradeca-4,8,12-enoate | C27H44O2 | 16898-88-7 | Details |
| Lanopepden mesylate | C23H38FN7O7S | 1441390-17-5 | Details |
| ER-34122 | C27H26ClN3O5 | 179325-62-3 | Details |
| UniPR505 | 2938227-14-4 | Details |
| FK-330 dihydrate | C29H30ClF3N6O5 | 682813-92-9 | Details |
| Inbakicept | 2135939-52-3 | Details |
| LEM-14-1189 | 2987501-17-5 | Details |
| EPZ033294 | C20H22ClN7O | 1887195-17-6 | Details |
| Crobenetine | C25H33NO2 | 221019-25-6 | Details |
| Cisd2 agonist 1 | 2916371-54-3 | Details |
| CM-352 | 1542205-83-3 | Details |
| Fluparoxan hydrochloride | C10H11ClFNO2 | 105227-44-9 | Details |
| YM-58790 | C27H31N3O2 | 168830-70-4 | Details |
| Tallimustine HCl | C32H39Cl3N10O4 | 118438-45-2 | Details |
| Impromidine hydrochloride | C14H24ClN7S | 65573-02-6 | Details |
| (3aR,9aR)-Fluparoxan | 105182-47-6 | Details |
| PI5P4Ks-IN-2 | 2766854-03-7 | Details |
| TC-2216 | C12H17N3 | 646055-67-6 | Details |
| Fosopamine(HCl) | C9H14NO5P.ClH | 135962-35-5 | Details |
| VEGFR-3-IN-1 | C29H29ClF3N7OS | 2756668-73-0 | Details |
| Burapitant | C31H35Cl2F6N3O3 | 537034-22-3 | Details |
| SMS2-IN-2 | C19H13ClFN3O2 | 2241838-28-6 | Details |
| Glycopyrronium tosylate | C26H35NO6S | 1624259-25-1 | Details |
| Trapencaine | C22H34N2O3 | 76629-91-9 | Details |
| Enerisant HCl | C22H30N4O3.ClH | 1152749-07-9 | Details |
| SLC26A3-IN-1 | C23H18O4 | 307552-53-0 | Details |
| Lodoxamide ethyl | C15H14ClN3O6 | 53882-13-6 | Details |
| Laprafylline | C29H36N6O2 | 90749-32-9 | Details |
| EPZ032597 | C20H23N7O | 1887193-58-9 | Details |
| Ot-730 | C25H36N2O8 | 870809-51-1 | Details |
| Type II TRK?inhibitor 1 | 2937543-72-9 | Details |
| PROTAC EZH2 Degrader-1 | C54H67N7O8 | 2641601-67-2 | Details |
| KT-531 | C17H14F4N2O4S | 2490284-18-7 | Details |
| KRAS G12C inhibitor 56 | C32H39N7O4S | 2749963-77-5 | Details |
| PERK-IN-6 | C23H22N6O | 1337532-14-5 | Details |
| CVN636 | C19H20FNO4S | 2226732-62-1 | Details |
| Verazine | C27H43NO | 14320-81-1 | Details |
| YM281 | C56H71N7O9S | 2230914-84-6 | Details |
| KRAS G12C inhibitor 1R | C31H36ClFN6O2 | 2927439-07-2 | Details |
| Ac-Lys-Val-Cit-PABC-MMAE | C66H108N12O14 | 1650569-89-3 | Details |
| PCSK9-IN-3 | 2867496-34-0 | Details |
| N′-(2-Chloroethyl)-N-(4-methylcyclohexyl)-N-nitrosourea | C10H18ClN3O2 | 75219-93-1 | Details |
| HFY-4A | 2094810-82-7 | Details |
| Serazapine | C22H23N3O2 | 115313-22-9 | Details |
| MC-Val-Cit-PAB-Exatecan | C53H60FN9O12 | 2504068-28-2 | Details |
| FX-06 | C133H216N44O38 | 88650-17-3 | Details |
| MC-Val-Cit-PAB-NH-C2-NH-Boc | C36H54N8O10 | 1616727-22-0 | Details |
| Bi-Mc-VC-PAB-MMAE | C71H104N12O18 | 1620837-70-8 | Details |
| INX-SM-56 | C32H36N2O6S | 2734878-18-1 | Details |
| 7-Aminomethyl-10-methyl-11-fluoro camptothecin | C22H20FN3O4 | 2378616-23-8 | Details |
| Budipine Hydrochloride | C21H28ClN | 63661-61-0 | Details |
| Naluzotan hydrochloride | C23H39ClN4O3S | 740873-82-9 | Details |
| SJ995973 | 2882065-25-8 | Details |
| Anticonvulsant agent 2 | C21H17ClN2 | 75220-84-7 | Details |
| (6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid | C18H19NO2 | 89667-39-0 | Details |
| Product Total： Product Page： | ||||
| 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 | ||||